ZimVie Rounding Corner on Spine Turnaround

ZimVie reported 1Q23 orthopedic sales of $104.9 million, -8.1% compared to the first quarter of 2022.

The company’s spine sales declined due to competitive pressure and its departure from the Chinese market following volume-based procurement. However, some sales previously recognized by Zimmer Biomet are now ZimVie sales and partially...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us